China, EU Regulators Highlight Innovation, Access And Collaboration As Key Policy Aims

DIA China Meeting Hears Views

Former and incumbent regulatory officials from China and the European Union highlighted the need for supportive regulatory policies for the innovative drug sector at the recent DIA China annual meeting.

China EU relations
Regulatory collaboration between China, EU progressing steadily • Source: Shutterstock

As the global pharma industry experiences turbulence from the heightened geopolitical tensions between the US and China, former and incumbent regulatory officials from China and the European Union tried to inject the sector with reassurances of collaboration on innovation and access at the recent DIA China Annual Meeting.

From the China side, however, messages meant to offer relief may have come across as less than confident. In a...

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from China

More from Asia